Tradestie Institutional Equity Comparison Engine

ABSI vs NOVTU โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ABSI Overall Edge

ABSI Captures Institutional Edge (3โ€“0 Pillars ยท 6โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Absci Corporation Common Stock (ABSI) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ABSI trades at N/M Forward P/E with -9108.3% operating margin (-19.6% YoY revenue) versus NOVTU at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, ABSI sits in BREAKDOWN (15th %ile IV; Dealer Gamma Walls on Pro) against NOVTU sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
ABSI N/M vs NOVTU N/M Fwd P/E
Growth & Margin Winner ABSI
Op Margin -9108.3% vs N/A ยท YoY -19.6% vs N/A
Momentum & Technical Winner ABSI
1Y +192.6% vs -2.4% ยท 52W Pos 53% vs 11%
Options & Structure Winner ABSI
BREAKDOWN (15th %ile IV) vs UNCLASSIFIED (N/A IV)
ABSI NASDAQ
Absci Corporation Common Stock
Services-Commercial Physical & Biological Research
$7.72
-8.58% 1D
Market Cap $1.6B
1M Return -6.36%
1Y Return +192.61%
Forward P/E N/M
Unified AI Score
37.5 / 100 SELL
Tech 27.0 Fund 51.0 Flow 71.0 Mom 60.0
NOVTU US Equity
NOVTU
Institutional Equity
$50.76
-1.05% 1D
Market Cap N/A
1M Return -9.21%
1Y Return -2.38%
Forward P/E N/M
Unified AI Score
42.5 / 100 HOLD
Tech 30.0 Fund 45.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ABSI +192.61% NOVTU -2.38% Spread: +193.1 pp (ABSI Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ABSI TTM Op. Margin: -9108.3% NOVTU TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABSI vs NOVTU. Trailing 12-month operating profitability (ABSI -9108.3% vs NOVTU N/A) and valuation multiples (ABSI N/M vs NOVTU N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ABSI (6) vs NOVTU (2)
Institutional Metric ABSI NOVTU Criterion Row Winner
Market Capitalization Scale $1.6B N/A Larger Scale ABSI
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -19.6% N/A Higher Growth ABSI
Operating Margin (TTM) Profitability -9108.3% N/A Higher Margin ABSI
Net Profit Margin Profitability 0.0% N/A Higher Margin ABSI
Return on Equity (ROE) Capital Efficiency -58.6% N/A Higher ROE ABSI
52-Week Range Position Momentum 53% ($2โ€“$13) 11% ($48โ€“$77) Stronger Trend ABSI
Beta / 30D Volatility Risk Regime 3.31ฮฒ ยท 126% Vol 1.70ฮฒ ยท 65% Vol Lower Realized Risk NOVTU
Unified Institutional Score Composite Signal 37.5 / 100 (SELL) 42.5 / 100 (HOLD) Higher Composite NOVTU

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ABSI vs NOVTU Buy Guide
ABSI BREAKDOWN
97d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 15th %ile
IV Regime Compressed (<25th %ile)
Live ABSI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
NOVTU UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live NOVTU Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ABSI nor NOVTU registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.